|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-1-16
|
|
pubmed:abstractText |
Ibutilide may result in chemical cardioversion of atrial fibrillation and facilitates transthoracic cardioversion by lowering the defibrillation energy requirement. Whether routine pretreatment with ibutilide increases or decreases the cost of cardioversion is unknown. The purpose of this study was to compare the cost of outpatient transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1074-2484
|
|
pubmed:author |
pubmed-author:BakerR LRL,
pubmed-author:ChoughS PSP,
pubmed-author:FendrickA MAM,
pubmed-author:KimM HMH,
pubmed-author:KnightB PBP,
pubmed-author:MichaudG FGF,
pubmed-author:MoradyFF,
pubmed-author:OralHH,
pubmed-author:PelosiFFJr,
pubmed-author:SticherlingCC,
pubmed-author:StrickbergerS ASA,
pubmed-author:WasmerKK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
259-66
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment.
|
|
pubmed:affiliation |
Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor, MI 48109-0022, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
